Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma
Author:
Affiliation:
1. Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico Ii, Naples, Italy
2. Dermatology Department, Universidad Autónoma de Nuevo León, University Hospital ¨Dr. José Eleuterio González¨, Monterrey, Mexico
Funder
funding
Publisher
Informa UK Limited
Subject
Pharmacology (medical),General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/14740338.2022.1993819
Reference48 articles.
1. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline
2. PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma
3. Cutaneous Squamous Cell Carcinoma
4. Cutaneous squamous cell carcinoma
5. The incidence and risk factors of metastasis for cutaneous squamous cell carcinoma-implications on the T-classification system
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Lipid-based nanosystems: the next generation of cancer immune therapy;Journal of Hematology & Oncology;2024-07-19
2. Comprehensive approaches to preclinical evaluation of monoclonal antibodies and their next-generation derivatives;Biochemical Pharmacology;2024-07
3. Therapeutic Approaches for Non-Melanoma Skin Cancer: Standard of Care and Emerging Modalities;International Journal of Molecular Sciences;2024-06-27
4. Unaddressed Challenges in the Treatment of Cutaneous Melanoma?;Medicina;2024-05-28
5. Efficacy and Safety of Cemiplimab for the Management of Non-Melanoma Skin Cancer: A Drug Safety Evaluation;Cancers;2024-04-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3